Dose-Response Characteristics of Mibefradil, a Novel Calcium Antagonist, in the Treatment of Essential Hypertension
Year: 1997
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: American Journal of Hypertension
Author: S Oparil
Institutions: University of Alabama, University of Alabama at Birmingham
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1982690791